VX-702

Based on 69 reference(s) in Google Scholar 8 10 69

Axon 4219

CAS [479543-46-9]

MF C19H12F4N4O2
MW 404.32

VX-702

Description

VX-702 is an orally bioavailable p38 MAP kinase inhibitor developed to treat inflammatory diseases.

MAPK (p38) EC 2.7.11.24 Infectious Disease

Orally bioavailable p38 MAP kinase inhibitor

2-(2,4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide

Sold in collaboration with Chemietek

[479543-46-9]

Axon ID	Name	Description
1357	SD 169	MAPK inhibitor (p38α specific)	€60.00
1358	BIRB 796	MAPK inhibitor (p38 specific)	€65.00
1363	SB 203580	MAPK inhibitor (p38 specific)	€95.00
1364	SB 202190	MAPK inhibitor (p38 specific)	€95.00
1365	PD169316	MAPK inhibitor (p38 specific)	€95.00
1465	SB 203580 hydrochloride	MAPK inhibitor (p38 specific)	€70.00
1671	SCIO 469	MAPK inhibitor (p38 specific)	€120.00
1811	VX 745	Inhibitor of p38α MAP kinase	€90.00
1837	PH 797804	Inhibitor of p38α MAPK	€115.00
1895	LY 2228820	Inhibitor of p38 MAPK	€105.00
2444	SB 706504	Selective p38 MAPK inhibitor that targets a subset of inflammatory macrophage genes.	€125.00
5010	Naive Stem Cell NHSM inhibitor Set	Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs	€230.00
2786	(±)-PH 797804	Inhibitor of p38α MAPK	€115.00
2856	BMS 582949	Inhibitor of p38α MAPK	€155.00
3197	Mitochonic acid 5	Mitochondrial drug; Activator of MAPK-ERK-yap signalling	€90.00
3183	SR-318	Highly potent and selective type-II p38 α/β inhibitor	€120.00
3440	MK2 inhibitor III	Potent and selective MK-2 inhibitor	€120.00
3620	MAPK13 inhibitor compound 61	MAPK13 inhibitor (p38δ specific)	€140.00
2717	Apigenin	Selective inhibitor of Casein kinase 2 (CK2)	€70.00